The largest database of trusted experimental protocols
Protocol detail

Generating mKate2 Expression Under Xanf1 Promoter

To generate a construct expressing mKate2 under the control of Xanf1 promoter, the 2200 bp fragment of this promoter sufficient for specifically targeting the expression to the anterior neural plate [10 (link)] was subcloned into VspI (blunted)/AgeI sites of mKate2-N vector, instead of the multiple cloning site region and CMV (cytomegalovirus) promoter. For transgenic experiments, vectors were linearized by SfiI and purified using Qiagen columns. Transgenic embryos were generated by the REMI (restriction enzyme-mediated integration) technique exactly as described previously [10 (link)] and were analysed using a Leica MZFLIII fluorescent stereomicroscope with the rhodamine filter set: excitation filter 546/10 nm; suppression filter 565 nm. To visualize a fluorescent signal on tissue sections, transgenic embryos were fixed overnight in 4 % (w/v) formaldehyde in 0.1 % PBS, embedded in 3 % agarose in 0.1 % PBS and sectioned using a HB 650 Vibratome (Microme) in 50 μm sections. The animal work was performed in Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, in accordance with the regulations of the Department of Health and Human Services, National Institutes of Health.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Publication 2009
Agarose Animal Cytomegalovirus Embryos Formaldehyde Neural plate Restriction enzyme Rhodamine Tissue Transgenic Vectors

Corresponding Organization :

Other organizations : Institute of Bioorganic Chemistry, National High Magnetic Field Laboratory, Florida State University, Albert Einstein College of Medicine

Protocol cited in 30 other protocols

1

SARS-CoV-2 Variant S-Protein Antigen Constructs

The S-protein antigen constructs representing the different VOCs contained the following mutations compared to the WT variant (Wuhan Hu-1; GenBank: MN908947.3): deletion (Δ) of H69, V70 and Y144, N501Y, A570D, D614G, P681H, T716I, S982A, and D1118H in Alpha (B.1.1.7); L18F, D80A, D215G, L242H, R246I, K417N, E484K, N501Y, D614G, and A701V in Beta (B.1.351); and L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, and T1027I in Gamma(P.1). The genes were ordered as gBlock gene fragments (Integrated DNA Technologies) and cloned Pst I/Not I in a pPPI4 expression vector containing a hexahistidine (his) tag with Gibson Assembly (Thermo Fisher Scientific). All S constructs were verified by Sanger sequencing and the protein was subsequently produced in human embryonic kidney (HEK) 293 F cells (Thermo Fisher Scientific) and purified as previously described4 (link),9 (link).
+ Open protocol
2

SARS-CoV-2 Spike Protein Variant Expression

The mutations compared to the WT variant (Wuhan Hu-1; GenBank: MN908947.3) in the S proteins are depicted in S1 Table. The S constructs were ordered as gBlock gene fragments (Integrated DNA Technologies) and cloned in a pPPI4 expression vector containing a hexahistidine (his) tag with Gibson Assembly (ThermoFisher) [32 (link)]. All S constructs were verified by Sanger sequencing, subsequently produced in HEK293F cells (ThermoFisher), and purified as previously described [32 (link)].
+ Open protocol
3

Structural Analysis of SARS-CoV-2 Spike Variants

The 2P-stabilized S proteins
of the Wuhan strain (WT) and B.1.351
variant were described previously.12 (link),55 (link) The B.1.351
construct contained the following mutations compared to the WT variant
(Wuhan Hu-1; GenBank: MN908947.3): L18F, D80A, D215G, L242H, R246I,
K417N, E484K, N501Y, D614G, and A701V. Both S constructs were produced
in HEK293F suspension cells (ThermoFisher) and purified as previously
described.12 (link) For the human ACE2 receptor,
soluble ACE2 was generated as described previously12 (link) by using a gene encoding amino acids 18–740 of ACE2.
The IgGs and Fab fragments used in this study were produced as previously
described.12 (link),26 (link)
+ Open protocol

Variable analysis

independent variables
  • Xanf1 promoter fragment
dependent variables
  • MKate2 expression
control variables
  • VspI (blunted)/AgeI sites of mKate2-N vector
  • Multiple cloning site region and CMV (cytomegalovirus) promoter
  • Linearization by SfiI restriction enzyme
  • REMI (restriction enzyme-mediated integration) technique
positive controls
  • Previous experiments as described in reference [10 (https://pubmed.ncbi.nlm.nih.gov/15128667/)]
negative controls
  • Not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!